Northwest Biotherapeutics Stock Probability of Future OTC Stock Price Finishing Over 1.4

NWBO Stock  USD 0.60  0.07  13.21%   
Northwest Biotherapeutics' future price is the expected price of Northwest Biotherapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Northwest Biotherapeutics performance during a given time horizon utilizing its historical volatility. Check out Northwest Biotherapeutics Backtesting, Northwest Biotherapeutics Valuation, Northwest Biotherapeutics Correlation, Northwest Biotherapeutics Hype Analysis, Northwest Biotherapeutics Volatility, Northwest Biotherapeutics History as well as Northwest Biotherapeutics Performance.
  
Please specify Northwest Biotherapeutics' target price for which you would like Northwest Biotherapeutics odds to be computed.

Northwest Biotherapeutics Target Price Odds to finish over 1.4

The tendency of Northwest OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 1.40  or more in 90 days
 0.60 90 days 1.40 
close to zero percent
Based on a normal probability distribution, the odds of Northwest Biotherapeutics to move over $ 1.40  or more in 90 days from now is close to zero percent (This Northwest Biotherapeutics probability density function shows the probability of Northwest OTC Stock to fall within a particular range of prices over 90 days) . Probability of Northwest Biotherapeutics price to stay between its current price of $ 0.60  and $ 1.40  at the end of the 90-day period is about 44.07 .
Given the investment horizon of 90 days the otc stock has the beta coefficient of 1.67 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Northwest Biotherapeutics will likely underperform. Additionally Northwest Biotherapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Northwest Biotherapeutics Price Density   
       Price  

Predictive Modules for Northwest Biotherapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Northwest Biotherapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Northwest Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.604.23
Details
Intrinsic
Valuation
LowRealHigh
0.020.504.13
Details
Naive
Forecast
LowNextHigh
0.010.604.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.470.550.62
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Northwest Biotherapeutics. Your research has to be compared to or analyzed against Northwest Biotherapeutics' peers to derive any actionable benefits. When done correctly, Northwest Biotherapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Northwest Biotherapeutics.

Northwest Biotherapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Northwest Biotherapeutics is not an exception. The market had few large corrections towards the Northwest Biotherapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Northwest Biotherapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Northwest Biotherapeutics within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.62
β
Beta against NYSE Composite1.67
σ
Overall volatility
0.07
Ir
Information ratio -0.15

Northwest Biotherapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Northwest Biotherapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Northwest Biotherapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Northwest Biotherapeutics generated a negative expected return over the last 90 days
Northwest Biotherapeutics has some characteristics of a very speculative penny stock
Northwest Biotherapeutics has high historical volatility and very poor performance
Northwest Biotherapeutics has high likelihood to experience some financial distress in the next 2 years
The company currently holds 25.16 M in liabilities. Northwest Biotherapeutics has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Northwest Biotherapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Northwest Biotherapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Northwest Biotherapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Northwest to invest in growth at high rates of return. When we think about Northwest Biotherapeutics' use of debt, we should always consider it together with cash and equity.
Northwest Biotherapeutics currently holds about 9.43 M in cash with (38.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Northwest Biotherapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Northwest OTC Stock often depends not only on the future outlook of the current and potential Northwest Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Northwest Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding948.4 M
Cash And Short Term Investments15.2 M

Northwest Biotherapeutics Technical Analysis

Northwest Biotherapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Northwest OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Northwest Biotherapeutics. In general, you should focus on analyzing Northwest OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Northwest Biotherapeutics Predictive Forecast Models

Northwest Biotherapeutics' time-series forecasting models is one of many Northwest Biotherapeutics' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Northwest Biotherapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Northwest Biotherapeutics

Checking the ongoing alerts about Northwest Biotherapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Northwest Biotherapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Northwest Biotherapeutics generated a negative expected return over the last 90 days
Northwest Biotherapeutics has some characteristics of a very speculative penny stock
Northwest Biotherapeutics has high historical volatility and very poor performance
Northwest Biotherapeutics has high likelihood to experience some financial distress in the next 2 years
The company currently holds 25.16 M in liabilities. Northwest Biotherapeutics has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Northwest Biotherapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Northwest Biotherapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Northwest Biotherapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Northwest to invest in growth at high rates of return. When we think about Northwest Biotherapeutics' use of debt, we should always consider it together with cash and equity.
Northwest Biotherapeutics currently holds about 9.43 M in cash with (38.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check out Northwest Biotherapeutics Backtesting, Northwest Biotherapeutics Valuation, Northwest Biotherapeutics Correlation, Northwest Biotherapeutics Hype Analysis, Northwest Biotherapeutics Volatility, Northwest Biotherapeutics History as well as Northwest Biotherapeutics Performance.
Note that the Northwest Biotherapeutics information on this page should be used as a complementary analysis to other Northwest Biotherapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Northwest OTC Stock analysis

When running Northwest Biotherapeutics' price analysis, check to measure Northwest Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Northwest Biotherapeutics is operating at the current time. Most of Northwest Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Northwest Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Northwest Biotherapeutics' price. Additionally, you may evaluate how the addition of Northwest Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
CEOs Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Please note, there is a significant difference between Northwest Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Northwest Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Northwest Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.